High expression of the checkpoint molecule PD-1 on regulatory and helper CD4+ T cells in metastatic breast cancer patients with poor prognosis

Programmed Cell Death Ligand 1(PD-L1) Expression in Molecular Subtypes of Breast Cancer

Analysis of the cellular expression of checkpoint molecules on immune cells in patients with breast cancer: Thesis Abstract

Expression of Adenosine Receptors in Young Patients with Breast Cancer and its Association with High Proliferative Index

Assessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics

Immunohistochemical expression of programmed death-ligand 1 (PD-L1) in invasive duct carcinoma of the breast of no special type and correlation with patients' clinicopathological

Soluble CD44 is a promising biomarker with a prognostic value in breast cancer patients

High expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients

Investigating the role of Wnt and related signaling pathways in breast cancer patients: Thesis Abstract

Effect of neoadjuvant chemotherapy on circulating immune cells in breast cancer patients: A pilot study